Oncotype

17 gene assay that is done to gauge a woman’s’ chance of recurrence of her disease. This is the first test of its kind. Determines whether a patient will benefit from chemotherapy, as well as specific types of chemotherapy such as taxanes and anthracyclines.

For further help contact Product Support:

supporttxm@intrinsiq.com
Phone : (877)570-8721

Explore the latest news and information on IntelliDose by joining our community at www.idcommunity.com

 

© 2016 IntelliDose. All rights reserved. IntelliDose is a Division of IntrinsiQ, LLC. No portion of this publication may be copied, reproduced or incorporated into any other media without IntrinsiQ’s prior written consent. Portions Copyright © 2011 Cerner Multum, Inc. All rights reserved